Clinical Trials Directory

Trials / Completed

CompletedNCT03131609

Avoiding Bacterial Contamination of Clean Catch Urine Cultures in Ambulatory Patients in the Emergency Department

Status
Completed
Phase
Study type
Observational
Enrollment
1,471 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find the best cleaning and collection methods to obtain a 'non-contaminated' clean catch mid-stream urine sample to diagnose suspected urinary tract infection (UTI).

Detailed description

BACKGROUND: Urinary tract infection (UTI) is a major public health issue resulting in more than 3-million visits to Emergency Departments in the United States each year. As part of the diagnostic work up, a sterile urine sample is requested for culture. The preferred urine specimen is a "Clean Catch Midstream Urine Sample". When patients are ambulatory and competent, this is a self-obtained specimen in a private bathroom. If the urine is not collected in a sterile manner the urine sample may be 'contaminated' by bacteria that originate from the skin or genital area, and not from the urinary tract. This is often described by the clinical laboratory as 'mixed growth bacteria'. A contaminated sample may lead to a false-positive urine culture result. In a non-contaminated urine specimen, only a single bacterial growth is identified as the source of the infection. Mixed bacterial flora with two or more microorganisms makes interpretation of the urine culture more difficult and prone to error. The American College of Pathologists has published results of national laboratory surveys on Urine Culture Contamination in 1998 and 2008 that document the scope of the problem. SAMPLE: Adult ambulatory patients in the Emergency Department who have a suspected UTI and have a urine culture ordered by a physician. A total of 2000 patients will be enrolled (500 per group). This is estimated to result in 600 urine samples (150 per group). Written consent is not normally required for a self-obtained urine sample. The study will be explained and participants will verbally consent or decline to participate, as approved by the Institutional Review Board. SETTING: Emergency Department of an academic medical center. METHOD: This is a randomized controlled trial (RCT) with 4 groups that compare different patient self-cleaning and self-collection methods. All study supplies materials are commercially available in the United States. Each participant will be provided with study-specific visual aids for male or female participants and their randomly assigned group. The four groups are: Group 1: Standard moist wipes and standard collection container. Group 2: Silver impregnated moist wipes and standard collection container. Group 3: Standard moist wipes and funnel collection container. Group 4: Silver impregnated moist wipes and funnel collection container. The urine samples will be sent to the Hospital Microbiology Laboratory for analysis. Urine samples with a positive leuk-esterase pre-screen will be sent for urine culture. DATA ANALYSIS:This study is powered to detect a large effect size change in any study groups (2. 3. 4) compared with control (group 1). The sample size is sufficient to identify the method(s) with the lowest urine sample contamination rate.

Conditions

Interventions

TypeNameDescription
OTHERContainerAmbulatory patients in the Emergency Department who have a urine culture ordered by the physician receive one of four urine collection/hygiene options.
OTHERSilver Impregnated WipeAmbulatory patients in the Emergency Department who have a urine culture ordered by the physician receive one of four urine collection/hygiene options.
OTHERFunnelAmbulatory patients in the Emergency Department who have a urine culture ordered by the physician receive one of four urine collection/hygiene options.
OTHERCastile-soap wipeAmbulatory patients in the Emergency Department who have a urine culture ordered by the physician receive one of four urine collection/hygiene options.

Timeline

Start date
2015-09-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2017-04-27
Last updated
2020-04-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03131609. Inclusion in this directory is not an endorsement.